Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints By: MarketWatch November 14, 2022 at 02:13 AM EST The company said it would keep working on novel diagnostics and treatments for Alzheimer's and said it would present at the Clinical Trials on Alzheimer's Disease Conference. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints By: MarketWatch November 14, 2022 at 02:13 AM EST The company said it would keep working on novel diagnostics and treatments for Alzheimer's and said it would present at the Clinical Trials on Alzheimer's Disease Conference. Read More >>